Status:
UNKNOWN
Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
Lead Sponsor:
Patan Academy of Health Sciences
Collaborating Sponsors:
Gulmidarbar Rural Municipality
Dhurkot Rural Municipality
Conditions:
Acute Febrile Illness
Use of Antimicrobial Agents
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
In Health Posts of rural areas operated by the Government of Nepal, there are limitations of tests to differentiate between bacterial and viral infections. Due to this, health workers are obliged to p...
Detailed Description
The World Health Organization (WHO) defines antimicrobial resistance (AMR) as a situation where drugs used to treat microbial infection caused by bacteria, viruses, fungi and parasites no longer work ...
Eligibility Criteria
Inclusion
- History of reported fever or fever greater than 100.4◦F (38◦C) with duration of illness up to 7 days
- Duration of fever less than or equal to 7 days
- Can connect with mobile phone for follow up
Exclusion
- Child younger than 1 year
- Main complaint being trauma or injury
- Symptoms requiring hospital referral
- Impaired consciousness
- Inability to take oral medication
- Convulsions
- Confirmed malaria
- Confirmed urinary tract infection
- Local skin infection
- Dental abscess or infection
- Suspicion of tuberculosis
- Any symptom other than fever present for more than 14 days
- Any bleeding such as from skin, nose and gums.
Key Trial Info
Start Date :
February 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
924 Patients enrolled
Trial Details
Trial ID
NCT05292508
Start Date
February 26 2023
End Date
December 1 2023
Last Update
June 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paralmi Health Post
Resunga Nagarpalika, Lumbini, Nepal